Navigation Links
Access Pharmaceuticals Provides an Update on Advances In Its Cobalamin(TM) Oral Drug Delivery Product Development
Date:1/14/2009

Data demonstrates that new Cobalamin oral insulin and oral human growth hormone formulations provide significant pharmacological responses in preclinical models

DALLAS, Jan. 14 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) provided an update today on its Cobalamin(TM) oral drug delivery product development programs. The proprietary Cobalamin(TM) technology utilizes the body's natural vitamin B12 oral uptake mechanism to facilitate oral absorption of pharmaceuticals by a "Trojan horse" mechanism. Access has focused its Cobalamin product development program on the oral delivery of insulin and human growth hormone, two peptides which currently can only be given by injection. Since presenting promising results at a major conference in mid-2008, Access has made substantial improvements to the formulation technology. A new Cobalamin-coated insulin-containing nanoparticle formulation delivered orally provided a pharmacological response (lowering of blood glucose levels in an animal model of diabetes) equivalent to 90% of that achieved by insulin delivered subcutaneously. This represents a substantial oral bioavailability, indicating that this formulation has potential for clinical development and ultimate commercialization. Adaptation of this technology has provided a Cobalamin human growth hormone formulation that has demonstrated good efficacy, represented by more than 25% improvement in weight gain, when given orally in an established animal model. Access continues to move both products towards clinical development, and plans to submit an additional patent application to protect the improvements to the technology.

Cobalamin is Access' proprietary technology based upon the use of vitamin B12 for targeted delivery of drugs to disease sites and for oral drug delivery of drugs that otherwise have poor oral bioavailability. The Access development of a Cobalamin human growth hormone formulatio
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Access Family Services, Inc. Makes the List for the Second Year in a Row! Access Family Services 2008 Ranks No. 2851 on the Inc. 5000 With Three-Year Sales Growth of 128%
2. Access Family Services and Compass Adult Care Awarded Three Year Accreditation from CARF!
3. CVS/pharmacy Teams Up with Access Hollywood for an Award Season Gifting Suite That Gives Back
4. Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board
5. George Will Column Misguided in Touting Competitive Bidding as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled
6. Specialists On Call Expands Access to Emergency Neurology On-Call Services in North Carolina
7. Specialists On Call Expands Access to Emergency Neurology On-Call Services in Georgia
8. Specialists On Call Accelerating Access to Emergency Neurology On-Call Services in Florida
9. Specialists On Call Expands Access to Emergency Neurology On-Call Services in California
10. VA Data Show Home Health Technology Improves Access to Care
11. SEIU Janitors and Responsible Corporate Leaders Herald New Model for Making Health Care More Accessible and More Affordable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 2015 , ... doTERRA, the leading global essential oils company, is pleased to ... held the position as Director of the Hinckley Institute at the University of Utah, ... institute, Jowers states that he was ready for a new challenge, and out of ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... newly-diagnosed cancer patients, caregivers and medical professionals to chat with the CHN patient ... cancer. , “Receiving a cancer diagnosis is often the most traumatic experience of ...
(Date:7/6/2015)... ... July 06, 2015 , ... Health care systems and genomics projects have ... field to access and use this “Big Data” to improve health and cut costs ... Officer of the Mount Sinai Health System in New York City. Physicians will have ...
(Date:7/6/2015)... , ... July 06, 2015 , ... MD Now, the ... July 6. The newly constructed urgent care center will serve residents and visitors in ... addition to being MD Now’s 22nd South Florida location, the new facility will be ...
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community program in the Livonia, ... Youth and announced a new charity campaign to raise funds in support of the ... abuse. Livonia Save Our Youth is a coalition created especially to educate and empower ...
Breaking Medicine News(10 mins):Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3
... of Coalgate, 60km west of Christchurch, died of blood poisoning ... . , ,An independent report into his death ... conference attended by his family. ,The report cleared ... failed Carroll by not offering him the best care. ...
... enhancement to decrease volume loss around the eyes, leads ... reviewed four cases where patients were injected superficially; all ... not be injected superficially, especially around the eyes, says ... not act as a dermal filler, which would be ...
... mother of three from Brisbane, Queensland in Australia died on ... cruise liner. She was apparently felled by a toxic combination ... fantasy. ,She had gone on the cruise with ... was friends with. ,Toxicology reports later revealed ...
... state authorities in US have found that psychiatric patients receive ... They are punched and hit or held in restraints for ... a patient's arm was broken as a nurse forcibly removed ... the growing strain on the state's overcrowded emergency rooms, doctors, ...
... devices -- including one designed to look at an infants ... use a needle filled with anesthetic to numb individual nerves ... they can quickly block nerve function in selected areas of ... patients from use of general anesthesia and sends them home ...
... number of lymph nodes that contain evidence of cancer ... chemotherapy and radiation to a treatment plan prior ... , The authors say their finding is particularly important ... to neoadjuvant therapies has been on the primary tumour ...
Cached Medicine News:Health News:New Zealand Authorities Concerned With Overcrowding in Hospitals 2Health News:New Zealand Authorities Concerned With Overcrowding in Hospitals 3Health News:Inquest of Date-rape Drug Victim Attracts Wide Attention in Australia 2Health News:Inquest of Date-rape Drug Victim Attracts Wide Attention in Australia 3Health News:Psychiatric Patients Ill-treated in Emergency Rooms, US Officials Say 2Health News:Psychiatric Patients Ill-treated in Emergency Rooms, US Officials Say 3Health News:Psychiatric Patients Ill-treated in Emergency Rooms, US Officials Say 4Health News:Mayo Clinic Physicians Have Adapted Real-time 3-D Ultrasound Imaging Devices 2Health News:Nodal Status is the Best Predictor in Esophageal Cancer 2Health News:Nodal Status is the Best Predictor in Esophageal Cancer 3
(Date:7/6/2015)...   Cepheid (Nasdaq: CPHD ) today announced ... second quarter ended June 30, 2015 on Thursday, July ... The Company will host a management presentation at ... to discuss the results.  To access the live webcast, ... least 15 minutes before the scheduled start time to ...
(Date:7/6/2015)... 6, 2015  OncoSec Medical Inc. ("OncoSec") (NASDAQ: ... today announced the appointment of Joann V. Lofgren ... of Market Development, effective July 6, 2015. In this ... and executing on the company,s market and product development ... excited to welcome Joann to the OncoSec team and ...
(Date:7/5/2015)... 2015 Nihon University is pleased to ... Medical-Engineering Collaboration "Medicine Definitely Jumps Up with 8K" ... Tokyo, Japan . Many experts ... will present their achievements and future prospects on ... produced with 8K technology. (Documentation: ...
Breaking Medicine Technology:OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 2OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 3Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3
Lyphochek Hemostasis Control is a multi-analyte control to help monitor coagulation factor assays and selected thrombosis risk assays. Assayed values are available for most major instrumentation....
... Blind Performance Specimens are intended ... specimen handling and transportation guidelines, including ... Drug Testing Programs regulated by the ... Administration (SAMHSA), Health and Human Services ...
Liquichek Sedimentation Rate Control is a bilevel human whole blood based control designed to monitor both manual and automated methods for measuring erythrocyte sedimentation rates....
Liquichek Hematology Control (A) is an assayed hematology control for evaluating the performance of Abbott Cell-Dyn 1600, 1700, 3000, 3500 and 3700 analyzers with 5-part differential technology....
Medicine Products: